Congress Has 100 Days to Act

The medical device tax will go back into effect at the end of this year.

As the clock has continued to tick, we have heard voices across the country speak out against this tax.

We’ve heard from patient leaders like Tracey Dedering, who hope that lawmakers get rid of this tax so cancer “thrivers” can get the treatments they need. We’ve heard from medical professionals, like the American Dental Association, who are worried about the effects of device tax on patient care, innovation and cost. We’ve heard from members of the media, including the Wall Street Journal editorial board, who recognize that the device tax is a “nasty tax on medical innovation.” And we’ve heard from bipartisan lawmakers – nearly 300 of them! – who agree that it is time to fully repeal this tax once and for all.

So today as we begin the 100-day countdown, we as advocates – and all the voices who have joined us over the past year – must recommit ourselves to the fight for medical innovation. The efforts we have seen from our lawmakers, while important, will only be able to protect jobs and medical innovation if legislation is passed by December 31st.

Make sure your lawmakers understand the urgent need for action: send your letter now.

Click here to take action.

More Articles

Mark’s PET Imaging Story

August 3, 2023

In March 2011, I was diagnosed with prostate cancer with a Gleason score of 7 (out of 10).…

Read More

Enhancing Patient Safety: An Insight into Medical Device Servicing Standards  

July 20, 2023

Wes Bonebright has over two decades of experience in the medical device servicing industry. As an engineer, Bonebright…

Read More

Patient Spotlight: Bobby Krause

July 13, 2023

Just a few years ago, Bobby was a 39-year-old marketing executive who reveled in the joys of parenthood,…

Read More

What You Need to Know About Breast Cancer Screening Guidelines

June 27, 2023

It’s alarming that breast cancer rates are on the rising among younger women.  While current guidance recommends mammograms…

Read More